InvestorsHub Logo
Followers 9
Posts 1218
Boards Moderated 0
Alias Born 10/22/2010

Re: Pharmmoney post# 130856

Sunday, 08/08/2021 9:44:42 AM

Sunday, August 08, 2021 9:44:42 AM

Post# of 140474
Thought more about the redactions.

Why are there so many redactions? Is is strictly for Medtronic's benefit if titan was in such a money crunch that they had to utilize IP to stay afloat?

Everyone knew Medtronic was developing HUGO so why hide this information? We all knew what was going on?

Of course anything is possible but it would quite shocking if the agreement was not extended or that Medtronic would not buy an equity stake in Titan.

I also keep thinking of McNally's rating. Would it be possible that after everything was said and done that there was not a buyout? I do not a huge problem with apparent suppression of pps but there has to be an end game. There has to be news. I mean why hire a ton of staff and spend more money on a new facility in North Carolina if you were running out of money? And if there is no buyout, what do you suppose will happen to McNally? He is reaching the end of his rope.

It is apparent that pps is remaining relatively stable in anticipation of news. Shareholders are waiting and expecting big news. Things are coming to a head and I sure hope our CEO knows what he is doing as it would be embarassing to remove him from his position if possible.

I guess I believe there is a price to pay for agreeing to the redactions and that price is shareholder expectation of increased pps at the end of the agreement.
TIC TOC